Online Only Articles

Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban

A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy;Department of Clinical Sciences and Community Health, University of Milan, Italy
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy;Department of Clinical Sciences and Community Health, University of Milan, Italy;Laboratory of Clinical Chemistry and Microbiology, University of Milan, Italy
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milano, Italy;Department of Clinical Sciences and Community Health, University of Milan, Italy;Laboratory of Clinical Chemistry and Microbiology, University of Milan, Italy;Department of Pathophysiology and Transplantation, University of Milan, Italy
Vol. 103 No. 7 (2018): July, 2018 https://doi.org/10.3324/haematol.2017.185132